Rarity Bioscience superRCA technology assays

Wednesday, 12 March, 2025 | Supplied by: Beckman Coulter Australia


As part of a co-exclusive distribution agreement, Beckman Coulter Life Sciences will market and distribute Rarity Bioscience’s superRCA technology assays. The assays are claimed to accelerate the detection of mutations by using flow cytometry with logarithmically higher sensitivity compared to the current gold standard digital PCR (dPCR) method.

While traditional flow cytometry research analyses phenotypes, the platform combines a molecular assay based on rolling circle amplification and padlock probes with a flow cytometry readout for high sensitivity and specific multiplex detection of sequence variants, including single point DNA mutations. The assay offers high throughput, resulting in fast turnaround without the need for additional hardware, lowering the barriers to molecular research assays.

Online: www.beckman.com.au
Phone: 1800 060 878
Related Products

Invent Biotechnologies Minute Single Cell Nuclei Kits

The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...

Enzo Life Sciences Histamine ELISA Kit

The Enzo Life Sciences Histamine ELISA Kit is engineered to enable the ultra-sensitive detection...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd